以体脂百分比而非体质指数定义超重与肥胖
该研究基于美国国家健康与营养调查(NHANES)横断面数据,对16918名成年人(男8734人、女8184人)作相关性分析,以代谢综合征(MetSyn)为结局指标确定体脂百分比(%BF)的超重与肥胖阈值,并与BMI阈值比较。结果显示男性超重对应25%BF、肥胖对应30%BF,女性超重对应36%BF、肥胖对应42%BF,BMI对%BF的预测变异范围很宽。
要点
- 男性超重约为25%BF、肥胖约为30%BF,女性超重约为36%BF、肥胖约为42%BF。
- BMI判定的超重者中5%存在MetSyn,肥胖者中35%存在MetSyn。
- BMI预测%BF的变异范围很宽,提示可用更直接的体脂测量管理肥胖相关疾病。
核心结论
- 实用的人体成分估计方法如今可替代间接的BMI评估用于肥胖管理,阈值取自本研究。
研究设计与样本
- 对来自美国人群、通过美国国家健康与营养调查公共使用数据集获取的16918名成年人(男8734人、女8184人)横断面抽样数据作相关性分析。
主要发现
- 按BMI判定的超重(BMI>25 kg/m2)和肥胖(BMI>30 kg/m2)人群中,分别有5%和35%存在MetSyn。
- 男性18%BF以下无MetSyn病例,与「超重」等效(即5%的MetSyn个体)出现在25%BF,与「肥胖」等效(即35%的MetSyn个体)对应30%BF。
- 女性30%BF以下无MetSyn病例,「超重」出现在36%BF,「肥胖」对应42%BF。
- BMI与%BF的比较显示BMI预测%BF的变异范围很宽,凸显用更直接肥胖指标管理肥胖相关疾病的潜在重要性。
关键数值与推荐
- 临床相关「超重」可定义为男性25%BF、女性36%BF。
- 「肥胖」定义为男性30%BF、女性42%BF。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thresholds for overweight and obesity are currently defined by body mass index (BMI), a poor surrogate marker of actual adiposity (percent body fat [%BF]). Practical modern technologies provide estimates of %BF but medical providers need outcome-based %BF thresholds to guide patients. This analysis determines %BF thresholds based on key obesity-related comorbidities, exhibited as metabolic syndrome (MetSyn). These limits were compared to existing BMI thresholds of overweight and obesity. DESIGN: Correlational analysis of data from cross sectional sampling of 16 918 adults (8734 men and 8184 women) from the US population, accessed by the National Health and Nutrition Examination Survey public use datasets. RESULTS: Individuals measured by BMI as overweight (BMI > 25 kg/m2) and with obesity (BMI > 30 kg/m2) included 5% and 35% of individuals with MetSyn, respectively. For men, there were no cases of MetSyn below 18%BF, %BF equivalence to "overweight" (ie, 5% of MetSyn individuals) occurred at 25%BF, and "obesity" (ie, 35% of MetSyn individuals) corresponded to 30%BF. For women, there were no cases of MetSyn below 30%BF, "overweight" occurred at 36%BF, and "obesity" corresponded to 42%BF. Comparison of BMI to %BF illustrates the wide range of variability in BMI prediction of %BF, highlighting the potential importance of using more direct measures of adiposity to manage obesity-related disease. CONCLUSION: Practical methods of body composition estimation can now replace the indirect BMI assessment for obesity management, using threshold values provided from this study. Clinically relevant "overweight" can be defined as 25% and 36% BF for men and women, respectively, and "obesity" is defined as 30% and 42% BF for men and women.
引用
- Potter AW, Chin GC, Looney DP, et al. Defining Overweight and Obesity by Percent Body Fat Instead of Body Mass Index. J Clin Endocrinol Metab. 2025. PMID: 38747476. doi:10.1210/clinem/dgae341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。